Science Magazine | AAAS: Science Advances Follow In vivo engineering tumor cells to a universal “all-in-one” cancer vaccine with full antigen spectrum | Science Advances Tumors are reprogrammed in vivo into a universal vaccine, triggering a robust immune response to eradicate cancer. https://www.science.org/doi/10.1126/sciadv.aee5201 science.org
